The Journal of Infection in Developing Countries 7(3):289-292
Asthma is one of the neglected diseases in Africa with a high prevalence. Allergic fungal diseases have been reported to complicate asthma progression and treatment outcomes. However, data about fungal asthma and its associated complications are limited in Africa. We aimed to estimate the burden of ...fungal asthma among adults and children in Africa using a systematic review.
more
Article published in: Journal of Intensive Care (2015) 3:16
SODIS manual - updated version
The SODIS manual contains detailed information about technical and promotional aspects of the SODIS method.
Former version also available in French, Portuguese, Spanish, Uzbek, Russian
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
PLOS ONE | https://doi.org/10.1371/journal.pone.0196380 May 15, 2018
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
Analysis of microfilaria prevalence data from 430 communities
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Journal of Microbiology and Infectious Diseases / 2015; 5 (3): 110-113
JMID, doi: 10.5799/ahinjs.02.2015.03.0187
February 2020Earth's Future 8(2):e2019EF001377.The water planetary boundary attempts to provide a global limit to anthropogenic water cycle modifications, but it has been challenging to translate and apply it to the regional and local scales at which water problems and management typically occur. We... develop a cross‐scale approach by which the water planetary boundary could guide sustainable water management and governance at subglobal contexts defined by physical features (e.g., watershed or aquifer), political borders (e.g., city, nation, or group of nations), or commercial entities (e.g., corporation, trade group, or financial institution).
more
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...serious adverse events (SAEs).
more
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018